SELLAS Life Sciences (SLS) Debt Ratio (2013 - 2018)
SELLAS Life Sciences (SLS) posted quarterly Debt Ratio of 0.0 for Q3 2018, down 99.19% year-over-year from 0.25 in Q3 2017, and down 99.19% quarter-over-quarter from 0.24 in Q2 2018.
SELLAS Life Sciences (SLS) Debt Ratio (2013 - 2018) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Debt Ratio for 6 consecutive years, with 0.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Debt Ratio fell 99.19% year-over-year to 0.0; the TTM figure through Sep 2018 stood at 0.0 (down 99.19% YoY), while the FY2017 annual figure was 0.33, up 23.12% from the prior year.
- Debt Ratio eased to 0.0 in Q3 2018 per SLS's latest filing, from 0.24 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.33 in Q4 2017 and bottomed at 0.0 in Q3 2018.
- Historically, Debt Ratio has averaged 0.17 across 5 years, with a median of 0.13 in 2014.
- Annual changes were most pronounced in 2016 — Debt Ratio surged 383.09% — and 2018, when it slumped 99.19%.
- SELLAS Life Sciences' Debt Ratio stood at 0.1 in 2014, then slumped by 44.73% to 0.06 in 2015, then surged by 361.42% to 0.27 in 2016, then gained by 23.12% to 0.33 in 2017, then plunged by 99.4% to 0.0 in 2018.
- Business Quant data shows SLS's Debt Ratio at 0.0 in Q3 2018, 0.24 in Q2 2018, and 0.29 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.24 |
| Mar 31, 2018 | 0.29 |
| Dec 31, 2017 | 0.33 |
| Sep 30, 2017 | 0.25 |
| Jun 30, 2017 | 0.22 |
| Mar 31, 2017 | 0.18 |
| Dec 31, 2016 | 0.27 |
| Sep 30, 2016 | 0.33 |
| Jun 30, 2016 | 0.31 |
| Mar 31, 2016 | 0.06 |
| Dec 31, 2015 | 0.06 |
| Sep 30, 2015 | 0.07 |
| Jun 30, 2015 | 0.06 |
| Mar 31, 2015 | 0.07 |
| Dec 31, 2014 | 0.10 |
| Sep 30, 2014 | 0.12 |
| Jun 30, 2014 | 0.13 |
| Mar 31, 2014 | 0.11 |
| Dec 31, 2013 | 0.11 |